Conversant Healthcare Systems

Conversant Healthcare Systems provides cancer blood specimens to academic and commercial researchers. The Company's highly-characterized biospecimens are gathered throughout disease progression and correlated with clinical and diagnostic data. With these biospecimens, researchers can further understand the biology of diseases in order to develop better diagnostic tests, more accurate prognostic indicators eg. biomarker, and more effective treatment options eg. personalized medicine.